A variant in a gene involved with inflammation and the immune response is linked with a decreased risk of lung cancer. The results add to the growing body of literature implicating these processes in the development of lung cancer.
A variant in a gene involved with inflammation and the immune response is linked with a decreased risk of lung cancer. The results add to the growing body of literature implicating these processes in the development of lung cancer.